[Heart rate variability, adrenomedullin and B-type natriuretic peptide before and after transcatheter closure in children with patent ductus arteriosus]

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Apr;38(4):334-6.
[Article in Chinese]

Abstract

Objective: To observe the changes of heart rate variability (HRV), adrenomedullin (ADM) and B-type natriuretic peptide (BNP) before and after transcatheter closure in children with patent ductus arteriosus.

Methods: HRV spectral values (TF, VLF, LF, HF, LF/HF) were detected by 24 dynamic electrocardiogram and the concentrations of plasma ADM and BNP were measured in 55 children with patent ductus arteriosus (Group PDA, n = 55) before and 3(rd) day, 3(rd) month after transcatheter closure therapy, and in 60 normal children (Group C).

Results: (1) Compared with Group C, the HRV spectral values (TF, VLF, HF) were significantly lower (all P < 0.01), LF/HF and the concentrations of plasma ADM, BNP were significantly higher in patients with PDA before transcatheter closure (all P < 0.01). (2) Compared with the values before transcatheter closure values, plasma ADM were significantly reduced at 3(rd) day and 3(rd) month after transcatheter closure (P < 0.01), the HRV spectral values (TF, VLF, HF) were significantly increased while LF/HF and plasma BNP were significantly decreased at 3(rd) month after transcatheter closure (P < 0.01 or P < 0.05).

Conclusions: HRV and plasma ADM, BNP improved significantly post transcatheter closure in children with patent ductus arteriosus.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenomedullin / blood*
  • Cardiac Catheterization
  • Child
  • Ductus Arteriosus, Patent / blood*
  • Ductus Arteriosus, Patent / physiopathology*
  • Ductus Arteriosus, Patent / therapy
  • Female
  • Heart Rate*
  • Humans
  • Male
  • Natriuretic Peptide, Brain / blood*
  • Young Adult

Substances

  • Natriuretic Peptide, Brain
  • Adrenomedullin